首页> American journal of cancer research> TIM-3 transcriptomic landscape with clinical and immunomic correlates in cancer.

TIM-3 transcriptomic landscape with clinical and immunomic correlates in cancer.

导出 OA

翻译打印收藏纠错

第一作者： Jibran,Ahmed

第一单位： Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institute of Health Bethesda, MD, The United Sates.

作者： Jibran,Ahmed ^[1] ; Daisuke,Nishizaki ^[2] ; Hirotaka,Miyashita ^[3] ; Suzanna,Lee ^[2] ; Mary K,Nesline ^[4] ; Sarabjot,Pabla ^[4] ; Jeffrey M,Conroy ^[4] ; Paul,DePietro ^[4] ; Jason K,Sicklick ^[5] ; Shumei,Kato ^[2] ; Razelle,Kurzrock ^[6]

作者单位： Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institute of Health Bethesda, MD, The United Sates. ^[1] Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center La Jolla, CA, The United States. ^[2] Dartmouth Cancer Center, Hematology and Medical Oncology Lebanon, NH, The United States. ^[3] OmniSeq Inc. (Labcorp) Buffalo, NY, The United States. ^[4] Department of Surgery, Division of Surgical Oncology, University of California San Diego San Diego, CA, The United States.;Department of Pharmacology, University of California San Diego San Diego, CA, The United States.;Moores Cancer Center, University of California San Diego La Jolla, CA, The United States. ^[5] WIN Consortium Paris, France.;MCW Cancer Center and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin Milwaukee, WI, The United States. ^[6]

关键词 RNA expression TIM-3 immune-checkpoint inhibitors solid tumors

DOI 10.62347/MQFF6404

PMID 38859842

发布时间 2024-06-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交